The Univ. of Pittsburgh has received a $2.7 million contract from the Department of Health and Human Services to develop therapies for hematopoietic syndrome, bone marrow stromal cell loss and vascular injury resulting from acute exposure to ionizing radiation. Contract funds are designed to assist selected candidate projects through clinical Phase 2 and not higher.